Literature DB >> 7047455

The effects of gliclazide in diabetes: a comparison with tolbutamide.

M J Berber, G H Tomkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7047455     DOI: 10.1007/bf02940142

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  8 in total

1.  Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.

Authors:  O Ponari; E Civardi; S Megha; M Pini; D Portioli; A G Dettori
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

Review 2.  High density lipoproteins.

Authors:  J Witztum; G Schonfeld
Journal:  Diabetes       Date:  1979-04       Impact factor: 9.461

3.  Long-term tolbutamide treatment after myocardial infarction. A clinical and biochemical study of 178 patients without overt diabetes.

Authors:  J Paasikivi
Journal:  Acta Med Scand Suppl       Date:  1970

4.  Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function.

Authors:  L J Klaff; A I Vinik; W P Jackson; E Malan; L Kernoff; P Jacobs
Journal:  S Afr Med J       Date:  1979-08-18

5.  A rapid micro-scale method for the measurement of Haemoglobin A1(a+b+c).

Authors:  S G Welch; B J Boucher
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

Review 6.  Diabetes: the genetic connections.

Authors:  D A Pyke
Journal:  Diabetologia       Date:  1979-12       Impact factor: 10.122

7.  Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus.

Authors:  G D Calvert; J J Graham; T Mannik; P H Wise; R A Yeates
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

8.  Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects.

Authors:  M B Mattock; J H Fuller; P S Maude; H Keen
Journal:  Atherosclerosis       Date:  1979-12       Impact factor: 5.162

  8 in total
  3 in total

1.  Gliclazide: the effects on lipids in type II diabetes.

Authors:  M Delargy; M McGovern; A Johnson; G H Tomkin
Journal:  Ir J Med Sci       Date:  1985-03       Impact factor: 1.568

Review 2.  Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.

Authors:  B Holmes; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 3.  Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.

Authors:  K J Palmer; R N Brogden
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.